| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |